Ammax Bio
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
333 Twin Dolphin Dr Ste 370, Redwood Cit...Website
www.ammaxbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ammax Bio
AmMax Bio Inc. is focused on developing next-generation cancer treatments, with a strong emphasis on its oncology pipeline, particularly the lead program AMB-066. The company has demonstrated a robust safety profile and promising preclinical data through six completed clinical trials. Their target clients include patients with colorectal cancer, specifically those with minimal residual disease, as evidenced by their ongoing Phase 2 studies. AmMax Bio aims to advance innovative therapies in collaboration with leading institutions like MD Anderson Cancer Center.Explore more
Ammax Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ammax Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Ammax Bio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Ammax Bio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Ammax Bio has new funding data
Earning: See what the market has to say on Ammax Bio recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Ammax Bio
Check if Ammax Bio has recently received funding, and reach out quickly before it becomes old news!
Ammax Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Ammax Bio launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Ammax Bio
Compare insights from companies similar to Ammax Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ammax Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ammax Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ammax Bio.
Ammax Bio Tech Stack
A closer look at the technologies used by Ammax Bio
See more technologies
Ammax Bio News & Media
AmMax Bio Announces Presentation at BIO-Europe Spring 2025
REDWOOD CITY, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company developing innovative therapeutics in oncology, today announced that Laura Zhu, Ph.D., MBA, the Company’s Chief Business Officer, will present at the 2025 BIO-Europe Spring Convention to be held March 17-19, 2025, in Milan, Italy. The presentation will take place on Tuesday, March 18, 2025, at 9:45 a.m. CET in Coral 1 on Level 2 of the AllianzAmMax Bio Announces First Patient Dosed in Phase 2a Study Evaluating AMB-066 in Patients with Colorectal Cancer Minimal Residual Disease
AMB-066 is a potential first-in-class treatment for CRC MRDAmMax Bio and MD Anderson Announce Agreements to Advance Development of AMB-066 in Colorectal Cancer Patients with Minimal Residual Disease
AmMax Bio and MD Anderson to Advance Development of AMB-066 in Colorectal Cancer Patients with Minimal Residual DiseaseAmMax Bio to Present at the Oppenheimer Healthcare Private Company Showcase
Oncology pipeline led by first-in-class treatment for patients suffering from colorectal cancer with minimal residual disease (CRC MRD) Oncology pipeline led by first-in-class treatment for patients suffering from colorectal cancer with minimal residual disease (CRC MRD)
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ammax Bio
Sign Up For FreeTo access detailed company insights
AmMax Bio Inc. is focused on developing next-generation cancer treatments, with a strong emphasis on its oncology pipeline, particularly the lead program AMB-066. The company has demonstrated a robust safety profile and promising preclinical data through six completed clinical trials. Their target clients include patients with colorectal cancer, sp... Read More
